Top 3 Stocks That Recovered Sharply in 2026 - 18 September 2026

2026 has been a rough year for several parts of the Indian stock market. Crude oil has stayed expensive, global interest rates remain a concern and geopolitical tensions have kept investors on edge. These factors have led to sharp swings in stock prices.

Some stocks, however, have managed to turn around after falling heavily earlier in the year. The recovery has come alongside better business numbers in some cases. For others, buying interest returned after steep corrections.

The broader economy has also remained resilient. India's real GDP grew 7.8% YoY in Q1 FY27. Investment activity remained strong, with gross fixed capital formation rising 11.9%. Industrial production grew 6.7% in July. Exports have added to the positive picture. Merchandise exports rose 26.1% YoY to $43.8 billion in August.

Here are three stocks that have made a strong comeback from their 2026 lows.

1. Tega Industries Ltd

Tega Industries Ltd supplies specialised products to the mining and mineral processing industries. Its products include polymer-based mill liners and other consumables used in mineral beneficiation and bulk material handling.  The stock started the year on a weak note. It fell nearly 25% from January 1 and hit its 2026 low on July 30.

The fall was followed by a sharp rebound. From that low, the stock has gained around 31%. One reason investors may have taken notice is the company's recent revenue growth. Tega Industries reported revenue of ₹1,723 crore in Q1 FY27, compared with ₹356 crore a year earlier. That marked a 384% YoY increase.

Shareholding data also showed higher FII participation. FII holding increased from 2.14% in March 2026 to 2.80% in June 2026. At the end of June, promoters owned 67.51% of the company and DIIs held 18.68%.

2. eClerx Services Ltd

eClerx Services Ltd works with global businesses on digital operations, analytics, automation and business process management. The company serves clients across financial services, retail, manufacturing, travel and technology.

Its stock went through a much deeper correction than Tega Industries. The share price dropped nearly 45% from the start of 2026 before hitting a recent low. Since then, it has recovered around 53%.

The company's financial numbers have remained supportive. Q1 FY27 revenue rose 23.8% YoY to ₹1,170.2 crore. Operating revenue was up 23.3% at ₹1,152.4 crore. EBITDA increased 20.6% to ₹283.1 crore, while net profit rose 16% to ₹164.3 crore.

The full-year numbers also show the company's growth over the past year. Sales increased from ₹3,366 crore in FY25 to ₹4,117 crore in FY26. Net profit moved up from ₹541 crore to ₹706 crore. That combination of revenue growth and profitability has come as the stock tries to recover from its earlier decline.

3. GlaxoSmithKline Pharmaceuticals Ltd

GlaxoSmithKline Pharmaceuticals Ltd has a presence across vaccines, respiratory medicines and specialty therapies. The company also has a portfolio of established medicines in the Indian market. Its shares fell nearly 15% from the beginning of 2026 before reaching a recent low. The stock has since recovered around 36% from that level.

The company has also improved its profitability. FY26 sales stood at ₹3,822 crore, compared with ₹3,749 crore in FY25. Operating profit increased from ₹1,179 crore to ₹1,309 crore. Net profit rose from ₹928 crore to ₹1,036 crore. The operating margin improved from 31% to 34%.

GSK carried that momentum into the June quarter. Q1 FY27 revenue increased 15% YoY to ₹924 crore, while profit after tax rose 24% to ₹253 crore. The growth was spread across vaccines, respiratory products and specialty medicines. FII ownership also increased slightly. Their holding moved from 4.62% in March 2026 to 4.79% in June 2026. Promoter ownership remained unchanged at 75%.